Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Marie-Pierre Chaury"'
Autor:
Sylvain Thépot, Raouf Ben Abdelali, Sylvie Chevret, Aline Renneville, Odile Beyne-Rauzy, Thomas Prébet, Sophie Park, Aspasia Stamatoullas, Agnes Guerci-Bresler, Stéphane Cheze, Gérard Tertian, Bachra Choufi, Laurence Legros, Jean Noel Bastié, Jacques Delaunay, Marie Pierre Chaury, Laurence Sanhes, Eric Wattel, Francois Dreyfus, Norbert Vey, Fatiha Chermat, Claude Preudhomme, Pierre Fenaux, Claude Gardin
Publikováno v:
Haematologica, Vol 101, Iss 8 (2016)
The efficacy of azacitidine in patients with anemia and with lower-risk myelodysplastic syndromes, if relapsing after or resistant to erythropoietic stimulating agents, and the benefit of combining these agents to azacitidine in this setting are not
Externí odkaz:
https://doaj.org/article/dcc821d2ee5a454fb0d4fe2816dcf54e
Autor:
Charlotte Lacronique-Gazaille, Marie-Pierre Chaury, Alexandre Le Guyader, Jean-Luc Faucher, Dominique Bordessoule, Jean Feuillard
Publikováno v:
Haematologica, Vol 92, Iss 6 (2007)
Using a very simple flow cytometry protocol, we found that CD36 and CD117 on granulocytes and CD56 on monocytes were the major bone marrow phenotypic aberrations in patients with myelodysplasia, including CMML. CD56 on monocytes was associated with C
Externí odkaz:
https://doaj.org/article/e2891104e61b4e8db720dfa8640fbc7d
Autor:
Sylvie Chevret, Fatiha Chermat, Pierre Fenaux, Sophie Park, jean Noel Bastie, François Dreyfus, Raouf Ben Abdelali, Claude Preudhomme, Aline Renneville, Jacques Delaunay, Thomas Prebet, Stéphane Cheze, Claude Gardin, Bachra Choufi, Gérard Tertian, Sylvain Thepot, Odile Beyne-Rauzy, Eric Wattel, Marie Pierre Chaury, Norbert Vey, Laurence Legros, Laurence Sanhes, Agnès Guerci-Bresler, Aspasia Stamatoullas
Publikováno v:
Haematologica. 101:918-925
The efficacy of azacitidine in patients with anemia and with lower-risk myelodysplastic syndromes, if relapsing after or resistant to erythropoietic stimulating agents, and the benefit of combining these agents to azacitidine in this setting are not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9f26bb97a33680306a838650804856b
https://doi.org/10.3324/haematol.2015.140988
https://doi.org/10.3324/haematol.2015.140988
Autor:
Christian Rose, Aspasia Stamatoullas, Gfm, Pierre Morel, Agnès Guerci, D. Vassilief, François Dreyfus, Marie Pierre Chaury, Pierre Fenaux, Odile Beyne-Rauzy, Dalila Larbaa, Stéphane Cheze, Sabine Brechignac, Lydie Roy, Laurent Pascal
Publikováno v:
Leukemia Research. 34:864-870
Background Iron chelation therapy (CT) improves survival in thalassemia major but its beneficial effects on survival in MDS patients remain uncertain. Methods We analyzed, by multivariate analysis, survival and causes of deaths in 97 low or intermedi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2f063b07d529ce067f5686134e81ef27
https://doi.org/10.1016/j.leukres.2009.12.004
https://doi.org/10.1016/j.leukres.2009.12.004
Autor:
Sylvain, Thépot, Raphael, Itzykson, Valerie, Seegers, Christian, Recher, Emmanuel, Raffoux, Bruno, Quesnel, Jacques, Delaunay, Thomas, Cluzeau, Anne, Marfaing Koka, Aspasia, Stamatoullas, Marie-Pierre, Chaury, Caroline, Dartigeas, Stéphane, Cheze, Anne, Banos, Pierre, Morel, Isabelle, Plantier, Anne-Laure, Taksin, Jean Pierre, Marolleau, Cecile, Pautas, Xavier, Thomas, Francoise, Isnard, Blandine, Beve, Yasmine, Chait, Agnes, Guerci, Norbert, Vey, Francois, Dreyfus, Lionel, Ades, Norbert, Ifrah, Herve, Dombret, Pierre, Fenaux, Claude, Gardin
Publikováno v:
American journal of hematology. 89(4)
Limited data are available on azacitidine (AZA) treatment and its prognostic factors in acute myeloid leukemia (AML). One hundred and forty-nine previously untreated AML patients considered ineligible for intensive chemotherapy received AZA in a comp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ac35de4ca0d8a3da1cfbd52fab04d807
https://pubmed.ncbi.nlm.nih.gov/24375487
https://pubmed.ncbi.nlm.nih.gov/24375487
Autor:
Christian, Rose, Sabine, Brechignac, Dominique, Vassilief, Laurent, Pascal, Aspasia, Stamatoullas, Agnes, Guerci, Dalila, Larbaa, François, Dreyfus, Odile, Beyne-Rauzy, Marie Pierre, Chaury, Lydie, Roy, Stephane, Cheze, Pierre, Morel, Pierre, Fenaux
Publikováno v:
Leukemia research. 34(7)
Iron chelation therapy (CT) improves survival in thalassemia major but its beneficial effects on survival in MDS patients remain uncertain.We analyzed, by multivariate analysis, survival and causes of deaths in 97 low or intermediate 1 IPSS patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0cd53cd52da29864a023fee614db6cc3
https://pubmed.ncbi.nlm.nih.gov/20346508
https://pubmed.ncbi.nlm.nih.gov/20346508
Autor:
Lionel Ades, Borhane Slama, Charikleia Kelaidi, Christian Rose, Christine Lamberto, Françoise Boyer, Benoit de Renzis, Aspasia Stamatoullas, Marie-Pierre Chaury, Stéphane Cheze, Laurence Legros, Shanti Ame, Thorsten Braun, Fabien Pillard, Pierre Fenaux, Agnès Guerci, Damaj Ghandi, Francois Dreyfus, Tony Jernival, Edith Mortera, Marie C. Béné, Emmanuel Gyan, Anna Testu, Bachra Choufi, Odile Beyne-Rauzy, Pierre Cougoul
Publikováno v:
Blood. 114:3812-3812
Abstract 3812 Poster Board III-748 Background. DAR is a hyperglycosylated erythroblastic stimulating agent (ESA) with prolonged half life. Previous studies have shown high erythroid response rates with DAR +/− G-CSF in anemia of lower risk MDS (Man
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f577ca43a79a5f9a2504d6bab367d079
https://doi.org/10.1182/blood.v114.22.3812.3812
https://doi.org/10.1182/blood.v114.22.3812.3812
Autor:
Magali Donnard, Jean Feuillard, Dominique Bordessoule, Stephane Moreau, Nathalie Gachard, Franck Trimoreau, Pascal Turlure, Rachel Pradeau, Marie-Pierre Chaury
Publikováno v:
Blood. 104:1068-1068
The overall survival of patients with p 53 mutated gene acute myeloid leukaemia (AML) is significantly shorter than those of patients without mutations. The frequency of p53 gene mutations in AML ranges from 4 to 15% in populations from USA and Europ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7811ff4270c9103eeb162b3e7418941
https://doi.org/10.1182/blood.v104.11.1068.1068
https://doi.org/10.1182/blood.v104.11.1068.1068
Autor:
Thépot, Sylvain, Itzykson, Raphael, Seegers, Valerie, Recher, Christian, Raffoux, Emmanuel, Quesnel, Bruno, Delaunay, Jacques, Cluzeau, Thomas, Marfaing Koka, Anne, Stamatoullas, Aspasia, Chaury, Marie-Pierre, Dartigeas, Caroline, Cheze, Stéphane, Banos, Anne, Morel, Pierre, Plantier, Isabelle, Taksin, Anne-Laure, Marolleau, Jean Pierre, Pautas, Cecile, Thomas, Xavier
Publikováno v:
American Journal of Hematology; Apr2014, Vol. 89 Issue 4, p410-416, 7p
Autor:
Natarajan-Amé, Shanti, Park, Sophie, Ades, Lionel, Vey, Norbert, Guerci-Bresler, Agnès, Cahn, Jean-Yves, Etienne, Gabriel, Bordessoule, Dominique, Ravoet, Christophe, Legros, Laurence, Cheze, Stephane, Stamatoullas, Aspasia, Berger, Elisabeth, Schmidt, Aline, Charbonnier, Aude, Chaury, Marie-Pierre, Braun, Thorsten, Fenaux, Pierre, Dreyfus, Francois
Publikováno v:
British Journal of Haematology; Jul2012, Vol. 158 Issue 2, p232-237, 6p, 2 Charts, 1 Graph